Skip to main content
logo
Active Biotech AB (publ) (STO:ACTI)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.07
+0.02 (0.40%)
Sep 2, 2026, 5:29 PM CET

Active Biotech AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-33.52-37.32-39.4-45.8-58.37-49.83
Depreciation & Amortization
1.51.61.641.681.51.28
Stock-Based Compensation
--0.010.170.690.28
Other Operating Activities
------0
Change in Accounts Receivable
1.111.11-1.09-0.170.030.99
Change in Other Net Operating Assets
-0.482.22-1.58-1.621.311.1
Operating Cash Flow
-31.4-32.4-40.42-45.74-54.85-46.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Sale (Purchase) of Intangibles
-----0.25-
Investing Cash Flow
-----0.25-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--1.71-1.64-1.62-1.76-1.02
Net Debt Issued (Repaid)
-1.71-1.71-1.64-1.62-1.76-1.02
Issuance of Common Stock
70.3378.5335.1943.4746.8376.25
Other Financing Activities
-10.12-6.72-1.96-1.68-1.31-2.15
Financing Cash Flow
58.570.131.5940.1643.7673.09

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
27.137.7-8.82-5.58-11.3426.92

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-20.09-7.03-34.26-29.14-32.65-27.12
Unlevered Free Cash Flow
-20.02-6.96-34.15-28.99-32.53-27.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--00-0
Change in Working Capital
0.633.33-2.67-1.791.342.1